{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:43:48Z","timestamp":1793943828235,"version":"4.8.0"},"reference-count":92,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:sec id=\"ab-yrv230003-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>In the last 25 years, functional magnetic resonance imaging drug cue reactivity (FDCR) studies have characterized some core aspects in the neurobiology of drug addiction. However, no FDCR-derived biomarkers have been approved for treatment development or clinical adoption. Traversing this translational gap requires a systematic assessment of the FDCR literature evidence, its heterogeneity, and an evaluation of possible clinical uses of FDCR-derived biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yrv230003-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To summarize the state of the field of FDCR, assess their potential for biomarker development, and outline a clear process for biomarker qualification to guide future research and validation efforts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yrv230003-6\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>The PubMed and Medline databases were searched for every original FDCR investigation published from database inception until December 2022. Collected data covered study design, participant characteristics, FDCR task design, and whether each study provided evidence that might potentially help develop susceptibility, diagnostic, response, prognostic, predictive, or severity biomarkers for 1 or more addictive disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yrv230003-7\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>There were 415 FDCR studies published between 1998 and 2022. Most focused on nicotine (122 [29.6%]), alcohol (120 [29.2%]), or cocaine (46 [11.1%]), and most used visual cues (354 [85.3%]). Together, these studies recruited 19\u202f311 participants, including 13\u202f812 individuals with past or current substance use disorders. Most studies could potentially support biomarker development, including diagnostic (143 [32.7%]), treatment response (141 [32.3%]), severity (84 [19.2%]), prognostic (30 [6.9%]), predictive (25 [5.7%]), monitoring (12 [2.7%]), and susceptibility (2 [0.5%]) biomarkers. A total of 155 interventional studies used FDCR, mostly to investigate pharmacological (67 [43.2%]) or cognitive\/behavioral (51 [32.9%]) interventions; 141 studies used FDCR as a response measure, of which 125 (88.7%) reported significant interventional FDCR alterations; and 25 studies used FDCR as an intervention outcome predictor, with 24 (96%) finding significant associations between FDCR markers and treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-yrv230003-8\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Based on this systematic review and the proposed biomarker development framework, there is a pathway for the development and regulatory qualification of FDCR-based biomarkers of addiction and recovery. Further validation could support the use of FDCR-derived measures, potentially accelerating treatment development and improving diagnostic, prognostic, and predictive clinical judgments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2023.5483","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T11:02:12Z","timestamp":1707303732000},"page":"414","source":"Crossref","is-referenced-by-count":46,"title":["Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity"],"prefix":"10.1001","volume":"81","author":[{"name":"Addiction Cue-Reactivity Initiative (ACRI) Network","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshiya","family":"Sangchooli","sequence":"additional","affiliation":[{"name":"Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Zare-Bidoky","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis"},{"name":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fathi Jouzdani","sequence":"additional","affiliation":[{"name":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Schacht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Bjork","sequence":"additional","affiliation":[{"name":"Institute for Drug and Alcohol Studies, Department of Psychiatry, Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Claus","sequence":"additional","affiliation":[{"name":"Department of Biobehavioral Health, The Pennsylvania State University, University Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Prisciandaro","sequence":"additional","affiliation":[{"name":"Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Psychology, The Pennsylvania State University, State College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"W\u00fcstenberg","sequence":"additional","affiliation":[{"name":"Field of Focus IV, Core Facility for Neuroscience of Self-Regulation (CNSR), Heidelberg University, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Potvin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Addiction, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooria","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Bach","sequence":"additional","affiliation":[{"name":"Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Baldacchino","sequence":"additional","affiliation":[{"name":"School of Medicine, University of St Andrews, St Andrews, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Beck","sequence":"additional","affiliation":[{"name":"Faculty of Health, Health and Medical University, Potsdam, Germany"},{"name":"Department of Psychiatry and Neurosciences, Charit\u00e9 Campus Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen T.","family":"Brady","sequence":"additional","affiliation":[{"name":"Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judson A.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rose","family":"Childress","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Courtney","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Filbey","sequence":"additional","affiliation":[{"name":"Center for BrainHealth, School of Behavioral and Brain Sciences, University of Texas at Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Garavan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara G.","family":"Ghahremani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Z.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke E.","family":"Goudriaan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands"},{"name":"Amsterdam Neuroscience, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica N.","family":"Grodin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A.","family":"Hanlon","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina"},{"name":"BrainsWay Inc, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Haugg","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Heilig","sequence":"additional","affiliation":[{"name":"Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heinz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurosciences, Charit\u00e9 Campus Mitte, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Holczer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Albert Szent-Gy\u00f6rgyi Health Centre, University of Szeged, Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth J.","family":"Van Holst","sequence":"additional","affiliation":[{"name":"Amsterdam Institute for Addiction Research, Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Juliano","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"McLean Hospital, Harvard Medical School, Belmont, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Kiefer","sequence":"additional","affiliation":[{"name":"Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Khojasteh Zonoozi","sequence":"additional","affiliation":[{"name":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayus T.","family":"Kuplicki","sequence":"additional","affiliation":[{"name":"Laureate Institute for Brain Research, Tulsa, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Leyton","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edythe D.","family":"London","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Mackey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Joseph","family":"McClernon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Mellick","sequence":"additional","affiliation":[{"name":"Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Morley","sequence":"additional","affiliation":[{"name":"Specialty of Addiction Medicine, Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid R.","family":"Noori","sequence":"additional","affiliation":[{"name":"McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Oghabian","sequence":"additional","affiliation":[{"name":"Neuroimaging and Analysis Group, Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Oliver","sequence":"additional","affiliation":[{"name":"TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Oklahoma City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Owens","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Vermont, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Paulus","sequence":"additional","affiliation":[{"name":"Laureate Institute for Brain Research, Tulsa, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Perini","sequence":"additional","affiliation":[{"name":"Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Rafei","sequence":"additional","affiliation":[{"name":"Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara A.","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajita","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Smolka","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazaleh","family":"Soleimani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spanagel","sequence":"additional","affiliation":[{"name":"Institute of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaughn R.","family":"Steele","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Tapert","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Vollst\u00e4dt-Klein","sequence":"additional","affiliation":[{"name":"Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagan R.","family":"Wetherill","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Witkiewitz","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of New Mexico, Albuquerque"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Life Science and Technology, Xidian University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Psychology, School of Humanities and Social Science, University of Science and Technology of China, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Verdejo-Garcia","sequence":"additional","affiliation":[{"name":"Turner Institute for Brain and Mental Health, Monash University, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Janes","sequence":"additional","affiliation":[{"name":"Cognitive and Pharmacological Neuroimaging Unit, National Institute on Drug Abuse, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy","family":"Kober","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zilverstand","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Ekhtiari","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis"},{"name":"Laureate Institute for Brain Research, Tulsa, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"yrv230003r1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1021\/acschemneuro.5b00067","article-title":"Biomarkers in substance use disorders.","volume":"6","author":"Volkow","year":"2015","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"yrv230003r2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis.","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"yrv230003r3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.drudis.2017.11.012","article-title":"The role of fMRI in drug development.","volume":"23","author":"Carmichael","year":"2018","journal-title":"Drug Discov Today"},{"key":"yrv230003r4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/bs.pbr.2015.10.002","article-title":"Neuroscience of drug craving for addiction medicine: from circuits to therapies.","volume":"223","author":"Ekhtiari","year":"2016","journal-title":"Prog Brain Res"},{"issue":"6","key":"yrv230003r5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/ntr\/ntab265","article-title":"Health effects of tobacco at the global, regional, and national levels: results from the 2019 Global Burden of Disease study.","volume":"24","author":"He","year":"2022","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"yrv230003r6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40429-015-0048-9","article-title":"Neuroimaging risk markers for substance abuse: recent findings on inhibitory control and reward system functioning.","volume":"2","author":"Heitzeg","year":"2015","journal-title":"Curr Addict Rep"},{"issue":"5","key":"yrv230003r7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neuron.2018.03.048","article-title":"Neuroimaging impaired response inhibition and salience attribution in human drug addiction: a systematic review.","volume":"98","author":"Zilverstand","year":"2018","journal-title":"Neuron"},{"issue":"8","key":"yrv230003r8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/archgenpsychiatry.2011.2026","article-title":"Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients.","volume":"69","author":"Beck","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yrv230003r9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cpt.v112.1","article-title":"Biomarker qualification at the European Medicines Agency: a review of biomarker qualification procedures from 2008 to 2020.","volume":"112","author":"Bakker","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"yrv230003r10","doi-asserted-by":"publisher","DOI":"10.1177\/1177271920974652","article-title":"Biomarkers: opportunities and challenges for drug development in the current regulatory landscape.","volume":"15","author":"Gromova","year":"2020","journal-title":"Biomark Insights"},{"issue":"3","key":"yrv230003r11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41596-021-00649-4","article-title":"A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus.","volume":"17","author":"Ekhtiari","year":"2022","journal-title":"Nat Protoc"},{"issue":"2","key":"yrv230003r12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/add.v110.2","article-title":"Neuroimaging craving: urge intensity matters.","volume":"110","author":"Wilson","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"yrv230003r13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.acra.2014.09.001","article-title":"Methods and challenges in quantitative imaging biomarker development.","volume":"22","author":"Abramson","year":"2015","journal-title":"Acad Radiol"},{"issue":"6","key":"yrv230003r14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41584-018-0005-9","article-title":"Biomarkers as drug development tools: discovery, validation, qualification and use.","volume":"14","author":"Kraus","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"yrv230003r15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neubiorev.2021.08.010","article-title":"The cue-reactivity paradigm: an ensemble of networks driving attention and cognition when viewing drug and natural reward-related stimuli.","volume":"130","author":"Hill-Bowen","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"yrv230003r16","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.euroneuro.2016.06.013","article-title":"Largely overlapping neuronal substrates of reactivity to drug, gambling, food and sexual cues: a comprehensive meta-analysis.","volume":"26","author":"Noori","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"yrv230003r17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/adb.2013.18.issue-1","article-title":"Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review.","volume":"18","author":"Schacht","year":"2013","journal-title":"Addict Biol"},{"issue":"3","key":"yrv230003r18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.physbeh.2012.03.009","article-title":"Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies.","volume":"106","author":"Tang","year":"2012","journal-title":"Physiol Behav"},{"issue":"2","key":"yrv230003r21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-012-2830-x","article-title":"Sensory modality of smoking cues modulates neural cue reactivity.","volume":"225","author":"Yalachkov","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"yrv230003r22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.pscychresns.2015.10.008","article-title":"The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults.","volume":"234","author":"Cortese","year":"2015","journal-title":"Psychiatry Res"},{"issue":"10","key":"yrv230003r23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.euroneuro.2018.07.102","article-title":"Sweet taste potentiates the reinforcing effects of e-cigarettes.","volume":"28","author":"Kroemer","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"yrv230003r24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.abrep.2018.01.002","article-title":"Anterior insula activation during inhibition to smoking cues is associated with ability to maintain tobacco abstinence.","volume":"7","author":"Gilman","year":"2018","journal-title":"Addict Behav Rep"},{"key":"yrv230003r25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2013.10.013","article-title":"Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies.","volume":"38","author":"Jasinska","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"yrv230003r26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/alcalc\/agz021","article-title":"Multisensory environments to measure craving during functional magnetic resonance imaging.","volume":"54","author":"Goodyear","year":"2019","journal-title":"Alcohol Alcohol"},{"issue":"2","key":"yrv230003r27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neuroimage.2006.09.032","article-title":"How long to scan? the relationship between fMRI temporal signal to noise ratio and necessary scan duration.","volume":"34","author":"Murphy","year":"2007","journal-title":"Neuroimage"},{"issue":"1","key":"yrv230003r28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41398-018-0219-2","article-title":"Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future.","volume":"8","author":"Comes","year":"2018","journal-title":"Transl Psychiatry"},{"issue":"1","key":"yrv230003r29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders.","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"3","key":"yrv230003r30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nn.4500","article-title":"Best practices in data analysis and sharing in neuroimaging using MRI.","volume":"20","author":"Nichols","year":"2017","journal-title":"Nat Neurosci"},{"key":"yrv230003r31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnhum.2018.00016","article-title":"An updated survey on statistical thresholding and sample size of fMRI studies.","volume":"12","author":"Yeung","year":"2018","journal-title":"Front Hum Neurosci"},{"issue":"28","key":"yrv230003r32","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1073\/pnas.1602413113","article-title":"Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates.","volume":"113","author":"Eklund","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"yrv230003r33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2042-6410-4-9","article-title":"The impact of sex on brain responses to smoking cues: a perfusion fMRI study.","volume":"4","author":"Wetherill","year":"2013","journal-title":"Biol Sex Differ"},{"issue":"3","key":"yrv230003r34","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1111\/ejn.v50.3","article-title":"Striatal alcohol cue-reactivity is stronger in male than female problem drinkers.","volume":"50","author":"Kaag","year":"2019","journal-title":"Eur J Neurosci"},{"issue":"1","key":"yrv230003r35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s42003-018-0073-z","article-title":"Small sample sizes reduce the replicability of task-based fMRI studies.","volume":"1","author":"Turner","year":"2018","journal-title":"Commun Biol"},{"issue":"12","key":"yrv230003r36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"5","author":"Degenhardt","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"yrv230003r37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/add.2014.109.issue-4","article-title":"Functional magnetic resonance imaging (fMRI) response to alcohol pictures predicts subsequent transition to heavy drinking in college students.","volume":"109","author":"Dager","year":"2014","journal-title":"Addiction"},{"issue":"5","key":"yrv230003r38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11682-017-9799-3","article-title":"Left frontoparietal network activity is modulated by drug stimuli in cocaine addiction.","volume":"12","author":"Costumero","year":"2018","journal-title":"Brain Imaging Behav"},{"issue":"2","key":"yrv230003r39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biopsych.2013.05.019","article-title":"Enhanced orbitofrontal cortex function and lack of attentional bias to cocaine cues in recreational stimulant users.","volume":"75","author":"Smith","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yrv230003r40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/acer.v45.1","article-title":"Clinical and neural correlates of reward and relief drinking.","volume":"45","author":"Burnette","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"yrv230003r41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/can.2016.0026","article-title":"Early versus late onset of cannabis use: differences in striatal response to cannabis cues.","volume":"1","author":"Wetherill","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"yrv230003r42","doi-asserted-by":"publisher","DOI":"10.1111\/adb.v26.4","article-title":"The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder.","volume":"26","author":"Shi","year":"2021","journal-title":"Addict Biol"},{"issue":"8","key":"yrv230003r43","doi-asserted-by":"publisher","first-page":"e186466","DOI":"10.1001\/jamanetworkopen.2018.6466","article-title":"Association of neural responses to drug cues with subsequent relapse to stimulant use.","volume":"1","author":"MacNiven","year":"2018","journal-title":"JAMA Netw Open"},{"key":"yrv230003r44","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/723632","article-title":"Sex differences and menstrual cycle phase-dependent modulation of craving for cigarette: an FMRI pilot study.","volume":"2014","author":"Mendrek","year":"2014","journal-title":"Psychiatry J"},{"issue":"4","key":"yrv230003r45","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1556\/2006.8.2019.75","article-title":"Functional neural changes and altered cortical-subcortical connectivity associated with recovery from Internet gaming disorder.","volume":"8","author":"Dong","year":"2019","journal-title":"J Behav Addict"},{"issue":"13","key":"yrv230003r46","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/npp.2017.74","article-title":"Predictors of naltrexone response in a randomized trial: reward-related brain activation, OPRM1 genotype, and smoking status.","volume":"42","author":"Schacht","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"yrv230003r47","doi-asserted-by":"publisher","DOI":"10.1111\/adb.v25.1","article-title":"Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone.","volume":"25","author":"Bach","year":"2020","journal-title":"Addict Biol"},{"issue":"11","key":"yrv230003r48","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1111\/acer.2014.38.issue-11","article-title":"Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.","volume":"38","author":"Mann","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"yrv230003r49","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00406-021-01259-7","article-title":"FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study.","volume":"271","author":"Bach","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"yrv230003r50","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.addbeh.2012.04.006","article-title":"Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI.","volume":"38","author":"Goudriaan","year":"2013","journal-title":"Addict Behav"},{"issue":"8","key":"yrv230003r51","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/scan\/nsx055","article-title":"Electrical stimulation reduces smokers\u2019 craving by modulating the coupling between dorsal lateral prefrontal cortex and parahippocampal gyrus.","volume":"12","author":"Yang","year":"2017","journal-title":"Soc Cogn Affect Neurosci"},{"key":"yrv230003r52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainresbull.2015.10.003","article-title":"Cue-reactivity in experienced electronic cigarette users: novel stimulus videos and a pilot fMRI study.","volume":"123","author":"Nichols","year":"2016","journal-title":"Brain Res Bull"},{"key":"yrv230003r53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116476","article-title":"Meta-analysis and review of functional neuroimaging differences underlying adolescent vulnerability to substance use.","volume":"209","author":"Tervo-Clemmens","year":"2020","journal-title":"Neuroimage"},{"issue":"4","key":"yrv230003r54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/09637214211026984","article-title":"The profound heterogeneity of substance use disorders: implications for treatment development.","volume":"30","author":"Carroll","year":"2021","journal-title":"Curr Dir Psychol Sci"},{"key":"yrv230003r55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.schres.2017.03.030","article-title":"Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: a randomized fMRI study.","volume":"194","author":"Machielsen","year":"2018","journal-title":"Schizophr Res"},{"issue":"14","key":"yrv230003r56","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1523\/JNEUROSCI.4977-13.2014","article-title":"Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.","volume":"34","author":"Young","year":"2014","journal-title":"J Neurosci"},{"issue":"5","key":"yrv230003r57","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/archgenpsychiatry.2010.190","article-title":"Effects of varenicline on smoking cue\u2013triggered neural and craving responses.","volume":"68","author":"Franklin","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"yrv230003r58","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hbm.v40.6","article-title":"The top-down regulation from the prefrontal cortex to insula via hypnotic aversion suggestions reduces smoking craving.","volume":"40","author":"Li","year":"2019","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"yrv230003r59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/acer.2016.40.issue-1","article-title":"Accelerated HF-rTMS protocol has a rate-dependent effect on dacc activation in alcohol-dependent patients: an open-label feasibility study.","volume":"40","author":"Herremans","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"yrv230003r60","doi-asserted-by":"publisher","first-page":"8724","DOI":"10.1038\/s41598-018-27057-1","article-title":"Effects of repeated transcranial direct current stimulation on smoking, craving and brain reactivity to smoking cues.","volume":"8","author":"Mondino","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"yrv230003r61","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40290-020-00343-y","article-title":"The NIMH \u2018Fast-Fail Trials\u2019 (FAST) initiative: rationale, promise, and progress.","volume":"34","author":"Grabb","year":"2020","journal-title":"Pharmaceut Med"},{"issue":"4","key":"yrv230003r62","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/adb.2016.21.issue-4","article-title":"Real-time functional magnetic resonance imaging neurofeedback can reduce striatal cue-reactivity to alcohol stimuli.","volume":"21","author":"Kirsch","year":"2016","journal-title":"Addict Biol"},{"issue":"1","key":"yrv230003r63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1503\/jpn.140200","article-title":"Individualized real-time fMRI neurofeedback to attenuate craving in nicotine-dependent smokers.","volume":"41","author":"Hartwell","year":"2016","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"yrv230003r64","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.brs.2023.04.015","article-title":"The importance of overlap: a retrospective analysis of electrical field maps, alcohol cue-reactivity patterns, and treatment outcomes for alcohol use disorder.","volume":"16","author":"McCalley","year":"2023","journal-title":"Brain Stimul"},{"issue":"6","key":"yrv230003r65","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/ejn.v51.6","article-title":"Brain responses and approach bias to social alcohol cues and their association with drinking in a social setting in young adult males.","volume":"51","author":"Groefsema","year":"2020","journal-title":"Eur J Neurosci"},{"key":"yrv230003r66","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107951","article-title":"Caudate reactivity to smoking cues is associated with increased responding to monetary reward in nicotine-dependent individuals.","volume":"209","author":"Molokotos","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"yrv230003r67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpsychires.2019.06.005","article-title":"Cue-elicited craving, thalamic activity, and physiological arousal in adult non-dependent drinkers.","volume":"116","author":"Wang","year":"2019","journal-title":"J Psychiatr Res"},{"issue":"6","key":"yrv230003r68","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/adb.2015.20.issue-6","article-title":"The effects of single nucleotide polymorphisms in glutamatergic neurotransmission genes on neural response to alcohol cues and craving.","volume":"20","author":"Bach","year":"2015","journal-title":"Addict Biol"},{"issue":"1","key":"yrv230003r69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/acer.2014.38.issue-1","article-title":"Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.","volume":"38","author":"Ray","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"issue":"24","key":"yrv230003r70","doi-asserted-by":"publisher","first-page":"10027","DOI":"10.1523\/JNEUROSCI.0695-13.2013","article-title":"Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence.","volume":"33","author":"Moeller","year":"2013","journal-title":"J Neurosci"},{"issue":"3","key":"yrv230003r71","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/npp.2012.195","article-title":"Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.","volume":"38","author":"Schacht","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"yrv230003r72","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118180","article-title":"It is never as good the second time around: brain areas involved in salience processing habituate during repeated drug cue exposure in treatment engaged abstinent methamphetamine and opioid users.","volume":"238","author":"Ekhtiari","year":"2021","journal-title":"Neuroimage"},{"issue":"6","key":"yrv230003r73","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/adb.2015.20.issue-6","article-title":"Predicting the future relapse of alcohol-dependent patients from structural and functional brain images.","volume":"20","author":"Seo","year":"2015","journal-title":"Addict Biol"},{"issue":"7","key":"yrv230003r74","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1177\/0956797620916786","article-title":"What is the test-retest reliability of common task-functional MRI measures? new empirical evidence and a meta-analysis.","volume":"31","author":"Elliott","year":"2020","journal-title":"Psychol Sci"},{"key":"yrv230003r75","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119046","article-title":"Reliability and stability challenges in ABCD task fMRI data.","volume":"252","author":"Kennedy","year":"2022","journal-title":"Neuroimage"},{"issue":"1","key":"yrv230003r76","doi-asserted-by":"publisher","DOI":"10.1111\/adb.v27.1","article-title":"Test-retest reliability of neural alcohol cue-reactivity: is there light at the end of the magnetic resonance imaging tube?","volume":"27","author":"Bach","year":"2022","journal-title":"Addict Biol"},{"issue":"1","key":"yrv230003r77","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroimage.2011.12.024","article-title":"Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies.","volume":"60","author":"Engelmann","year":"2012","journal-title":"Neuroimage"},{"key":"yrv230003r78","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuroimage.2019.03.070","article-title":"False-positive neuroimaging: undisclosed flexibility in testing spatial hypotheses allows presenting anything as a replicated finding.","volume":"195","author":"Hong","year":"2019","journal-title":"Neuroimage"},{"issue":"7","key":"yrv230003r79","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s007020170038","article-title":"Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics.","volume":"108","author":"Braus","year":"2001","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"yrv230003r80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084560","article-title":"Cue reactivity is associated with duration and severity of alcohol dependence: an FMRI study.","volume":"9","author":"Sjoerds","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"yrv230003r81","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/add.2010.105.issue-10","article-title":"Initial, habitual and compulsive alcohol use is characterized by a shift of cue processing from ventral to dorsal striatum.","volume":"105","author":"Vollst\u00e4dt-Klein","year":"2010","journal-title":"Addiction"},{"key":"yrv230003r82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneumeth.2015.01.001","article-title":"A comparison of region-of-interest measures for extracting whole brain data using survival analysis in alcoholism as an example.","volume":"242","author":"Reinhard","year":"2015","journal-title":"J Neurosci Methods"},{"issue":"8","key":"yrv230003r83","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00213-021-05842-7","article-title":"Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.","volume":"238","author":"Karl","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"yrv230003r84","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.15166","article-title":"Somatic and vicarious pain are represented by dissociable multivariate brain patterns.","volume":"5","author":"Krishnan","year":"2016","journal-title":"Elife"},{"issue":"7951","key":"yrv230003r85","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.1038\/s41586-023-05745-x","article-title":"Multivariate BWAS can be replicable with moderate sample sizes.","volume":"615","author":"Spisak","year":"2023","journal-title":"Nature"},{"issue":"3","key":"yrv230003r86","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bpsc.2023.01.003","article-title":"Deriving generalizable and interpretable brain-behavior phenotypes of cannabis use.","volume":"8","author":"Konova","year":"2023","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"2","key":"yrv230003r87","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41593-022-01228-w","article-title":"A neuromarker for drug and food craving distinguishes drug users from non-users.","volume":"26","author":"Koban","year":"2023","journal-title":"Nat Neurosci"},{"key":"yrv230003r88","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-3-030-05542-4","article-title":"The role of biomarkers in psychiatry.","volume":"1118","author":"Lozupone","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"yrv230003r90","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.dcn.2018.04.004","article-title":"Recruiting the ABCD sample: design considerations and procedures.","volume":"32","author":"Garavan","year":"2018","journal-title":"Dev Cogn Neurosci"},{"issue":"4","key":"yrv230003r91","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.neuroimage.2012.02.018","article-title":"The Human Connectome Project: a data acquisition perspective.","volume":"62","author":"Van Essen","year":"2012","journal-title":"Neuroimage"},{"key":"yrv230003r89","first-page":"203","volume-title":"Progress in Brain Research","author":"Mackey","year":"2016"},{"key":"yrv230003r19","unstructured":"Ekhtiari? H; ACRI Network. A systematic review on fMRI drug cue reactivity studies. Published online May 17, 2020. Accessed November 29, 2020. https:\/\/osf.io\/eb972\/"},{"key":"yrv230003r20","unstructured":"Addiction Cue Reactivity Initiative Network. Addiction Cue Reactivity Initiative Network (ACRIN). Accessed January 11, 2024. https:\/\/med.umn.edu\/addiction\/network\/acrin"},{"key":"yrv230003r92","unstructured":"University of Vermont. ENIGMA-Addiction homepage. Accessed September 5, 2023. https:\/\/www.enigmaaddictionconsortium.com\/"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2814652\/jamapsychiatry_sangchooli_2024_rv_230003_1711140309.58152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T11:25:41Z","timestamp":1712143541000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2814652"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.5483","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,1]]}}}